1. |
Reiner Z, TedeschiReiner E. New information on the pathophysiology of atherosclerosis [J]. Lijec Vjesn, 2001; 123(1-2)∶26.
|
2. |
Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis [J]. Circulation, 1997; 95(4)∶1062.
|
3. |
Colome C, MartinezGonzalez J, Vidal F, et al. Small oxidative changes in atherogenic LDL concentrations irreversibly regulate adhesiveness of human endothelial cells: effect of the lazaroid U74500A [J].Atherosclerosis, 2000; 149(2)∶295.
|
4. |
Cockerill GW, Saklatvala J, Ridley SH, et al. Highdensity lipoproteins differentially modulate cytokineinduced expression of Eselectin and cyclooxygenase2 [J]. Arterioscler Thromb Vasc Biol, 1999; 19(4)∶910.
|
5. |
Khan BV, Harrison DG, Olbrych MT, et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redoxsensitive transcriptional events in human vascular endothelial cells [J]. Proc Natl Acad Sci USA, 1996; 93(17)∶9114.
|
6. |
Keck C, Herchenbach D, Pfisterer J, et al. Effects of 17betaestradiol and progesterone on interleukin6 production and proliferation of human umbilical vein endothelial cells [J]. Exp Clin Endocrinol Diabetes, 1998; 106(4)∶334.
|
7. |
Walsh BA, Mullick AE, Banka CE, et al. 17betaestradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation [J]. J Lipid Res, 2000; 41(1)∶134.
|
8. |
Spyridopoulos I, Sullivan AB, Kearney M, et al. Estrogen receptor mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor [J]. Circulation, 1997; 95(6)∶1505.
|
9. |
Best PJ, Berger PB, Miller VM, et al. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin1 levels in postmenopausal women [J]. Ann Intern Med, 1998; 128(4)∶285.
|
10. |
Simoncini T, Maffei S, Basta G, et al. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule1 expression by different transcriptional mechanisms [J]. Circ Res, 2000; 87(1)∶19.
|
11. |
CaulinGlaser T, Farrell WJ, Pfau SE, et al. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease [J]. J Am Coll Cardiol, 1998; 31(7)∶1555.
|
12. |
Manduteanu L, Voinea M, Serban G, et al. High glucose induces enhanced monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM1, VCAM1 and CD18 [J]. Endothelium, 1999; 6(4)∶315.
|
13. |
Kado S, Nagata N. Circulating intercellular adhesion molecule1, vascular cell adhesion molecule1, and Eselectin in patients with type 2 diabetes mellitus [J]. Diabetes Res Clin Pract, 1999; 46(2)∶143.
|
14. |
Ribau JC, Hadcock SJ, Teoh K, et al. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients [J]. J Surg Res, 1999; 85(2)∶225.
|
15. |
Kol A, Bourcier T, Lichtman AH, et al. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages [J].J Clin Invest, 1999; 103(4)∶571.
|
16. |
Shen Y, Rattan V, Sultana C, et al. Cigarette smoke condensateinduced adhesion molecule expression and transendothelial migration of monocytes [J]. Am J Physiol, 1996; 270(5 Pt 2)∶H1624.
|
17. |
Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and charactersation of circulating antiendothelial cell IgG connective tissue diseases [J]. Clin Exp Immunol, 1998; 72(3)∶450.
|
18. |
Kawana S. The membrane attack complex of complement alters the membrane integrity of cultured endothelial cells: a possible pathophysiology for immune complex vasculitis [J]. Acta Derm Venereol, 1996; 76(1)∶13.
|
19. |
Miyagawa S, Shirakura R, Mikata S, et al. Functional feature of C5b8step lysis of swine endothelial cell transfected CD59 [J]. Transplant Proc, 1996; 28(2)∶597.
|
20. |
McCurry KR, Kooyman DL, Diamond LE, et al. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion [J]. Transplantation, 1995; 59(8)∶1177.
|
21. |
Li W, Tada T, Miwa T, et al. mRNA expression of complement components and regulators in rat arterial smooth muscle cells [J]. Microbiol Immunol, 1999; 43(6)∶585.
|
22. |
Seifert PS, Roth I, Schmiedt W, et al. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b9 attack, in human atherosclerotic lesions [J]. Atherosclerosis, 1992; 96(2-3)∶135.
|